Logo image
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Journal article   Open access   Peer reviewed

Ceramide is a cardiotoxin in lipotoxic cardiomyopathy

Tae-Sik Park, Yunying Hu, Hye-Lim Noh, Konstantinos Drosatos, Kazue Okajima, Jonathan Buchanan, Joseph Tuinei, Shunichi Homma, Xian-Cheng Jiang, E Dale Abel, …
Journal of lipid research, Vol.49(10), pp.2101-2112
10/2008
DOI: 10.1194/jlr.M800147-JLR200
PMCID: PMC2533410
PMID: 18515784
url
https://doi.org/10.1194/jlr.M800147-JLR200View
Published (Version of record) Open Access

Abstract

Ceramide is among a number of potential lipotoxic molecules that are thought to modulate cellular energy metabolism. The heart is one of the tissues thought to become dysfunctional due to excess lipid accumulation. Dilated lipotoxic cardiomyopathy, thought to be the result of diabetes and severe obesity, has been modeled in several genetically altered mice, including animals with cardiac-specific overexpression of glycosylphosphatidylinositol (GPI)-anchored human lipoprotein lipase (LpL(GPI)). To test whether excess ceramide was implicated in cardiac lipotoxicity, de novo ceramide biosynthesis was inhibited pharmacologically by myriocin and genetically by heterozygous deletion of LCB1, a subunit of serine palmitoyltransferase (SPT). Inhibition of SPT, a rate-limiting enzyme in ceramide biosynthesis, reduced fatty acid and increased glucose oxidation in isolated perfused LpL(GPI) hearts, improved systolic function, and prolonged survival rates. Our results suggest a critical role for ceramide accumulation in the pathogenesis of lipotoxic cardiomyopathy.
Cardiomyopathy, Dilated - pathology Fatty Acids, Monounsaturated - pharmacology Humans Heart Failure - physiopathology Glycogen Synthase Kinase 3 beta Serine C-Palmitoyltransferase - genetics Cattle Gene Deletion Myocardium - metabolism Cardiotoxins - antagonists & inhibitors Phosphorylation - drug effects Fatty Acids - metabolism Lipoprotein Lipase - metabolism Biomarkers - metabolism Heart - physiopathology Ceramides - metabolism Oxidation-Reduction Mice, Transgenic Serine C-Palmitoyltransferase - antagonists & inhibitors Survival Rate Ceramides - antagonists & inhibitors Heart Failure - metabolism Heart Failure - pathology Serine C-Palmitoyltransferase - metabolism Glycogen Synthase Kinase 3 - metabolism Cardiomyopathy, Dilated - metabolism Gene Expression Regulation - drug effects Animals Myocytes, Cardiac - drug effects Cardiomyopathy, Dilated - physiopathology Glycosylphosphatidylinositols - metabolism Glucose - metabolism Heart - drug effects Myocytes, Cardiac - metabolism Mice Cardiotoxins - metabolism

Details

Logo image